Breast cancer, the most prevalent disease in women globally, is brought on by uncontrolled cell development, which frequently results in a tumor that feels like a lump. Approximately 1 in 8 U.S women (13%) may get invasive breast cancer in their lifetime.

Moreover, breast cancer can start in the ducts or in the lobules, which are milk-producing glands that make up the breast tissue. In most cases, mammography, physical exams, or other imaging procedures like ultrasound-guided breast biopsies are used to find these breast abnormalities or masses. In the breast biopsy devices market, the introduction of the liquid biopsy method is a current trend.

This study covers

• Major factors driving the market and their impact during the short, medium, and long terms
• Market restraints and their impact during the short, medium, and long terms
• Recent trends and evolving opportunities for the market participants
• Historical and the present size of the market segments and understand their comparative future potential
• Potential of on-demand logistics services, so the market players make informed decisions on the sales of their offerings
• Competitive scenario of various market segments across key countries in several regions for uncovering market opportunities for the stakeholders
• Major players operating in the market and their service offerings

Breast Biopsy Devices Market Share

Previously, North America had the biggest share in the global breast biopsy devices market. Due to the increased prevalence of breast cancer, elderly demographics, high healthcare costs, strong economy. Developing private healthcare sector, the use of breast biopsy instruments is notably high in the U.S.

Additionally, the U.S. voluntary healthcare groups, professional societies, pharmaceutical and biotechnology firms, and research institutes are making significant investments in a range of medical and health-related R&D initiatives, which contributes to the market’s expansion in the nation.

Types of Breast Biopsies

Breast biopsy methods come in a variety of forms. Depending on where the breast lump is and how big it is, your doctor will decide what kind of biopsy you need.

• Core Needle Biopsy

During a core needle biopsy, a doctor removes fragments of breast tissue from a worrisome spot they have felt during an examination or have seen on an imaging test. The needle may be linked to a suction tool that enables the draw breast into the needle or to a spring-loaded instrument that propels the needle fast in and out of the tissue.

• Vacuum-Assisted Biopsy

A sample of breast tissue is extracted during a safe, minimally invasive technique called a vacuum-assisted core biopsy to be examined. Breast tissue samples are taken via vacuum-assisted core biopsy when breast imaging reveals extremely small abnormalities that are too small to detect.

Moreover, a surgery-based biopsy can be substituted by a vacuum-assisted core biopsy. Additionally, based on procedure type, the vacuum-assisted biopsy segment formerly had the biggest share of the breast biopsy devices market.

• Fine Needle Aspiration

A form of biopsy process is fine needle aspiration. In this, a little needle is introduced into a region of tissue or bodily fluid that seems abnormal. The sample obtained during a tiny needle aspiration can aid in making a diagnosis or ruling out illnesses like cancer, much like with other kinds of biopsies. Aspiration using a fine needle is often regarded as safe.

Hence, breast cancer is rapidly increasing all around the world; both genders such as men and women are in danger of breast cancer. Therefore, the demand for breast biopsy devices growing.

Breast Biopsy Devices Market Trends

A number of factors, such as the increasing cases of breast cancer, surging number of breast cancer screening programs. Burgeoning demand for minimally invasive surgeries, aging female population. Technological developments in breast imaging equipment, are projected to propel the breast biopsy devices market at a healthy CAGR of 11.1% during the forecast period (2018–2023).

The burgeoning breast biopsy device demand can be primarily ascribed to the growing prevalence of breast cancer worldwide. According to the International Agency for Research on Cancer (IARC), 2,261,419 cases of breast cancer were recorded worldwide in 2020. Furthermore, the World Health Organization (WHO) states that this cancer was responsible for 685,000 female deaths globally in 2020. This chronic disease arises in the lining cells (epithelium) of the lobules (15%) or ducts (85%) in the glandular tissue of the breast.

Breast Biopsy Devices Market Growth

In recent years, the use of the liquid biopsy technique has become a prominent trend in the breast biopsy devices market. Essentially the analysis of circulating tumor deoxyribonucleic acid (ctDNA). A liquid biopsy is a low-risk non-invasive process to study the genetic profile related to cancer. Detect cancerous tumors, and track the response of patients to the treatment. In this process. The DNA released into the circulatory system after the proliferation and death of cancer cells is taken out of the body via a syringe and analyzed.

The product segment of the breast biopsy devices market is classified into biopsy tables, biopsy wires, biopsy needles/guns, guidance systems, and others. Among these, the guidance systems category generated the highest revenue in 2017 because a single guidance system offers options for both stereotactic breast biopsy and tomosynthesis, which are needed in almost every breast biopsy procedure. Whereas, the biopsy needles/guns category is expected to exhibit the fastest growth in the forecast years.

Business Opportunities

Geographically, North America contributed the highest revenue to the breast biopsy devices market in 2017. The usage of these devices is substantially high in the U.S. due to the surging cases of breast cancer, escalating healthcare spending, booming private healthcare sector, and rising population of the elderly. Additionally, the prospering economy of the U.S. and mounting investments being made by federal, state, and local government agencies, research institutions, voluntary healthcare associations, professional societies, and pharmaceutical and biotechnology companies in healthcare research and development (R&D) will support the market growth.

Drivers and Trends

Whereas, the Asia-Pacific (APAC) breast biopsy devices market is projected to display the fastest growth during the forecast period. Due to the surging geriatric population, rising prevalence of breast cancer, soaring public awareness regarding the disease. Increasing technological advancements in these devices, and booming healthcare expenditure in the region. For instance, the IARC states that 178,361 women in India were diagnosed with breast cancer in 2020. Similarly, the National Breast Cancer Foundation, Australia, estimates nearly 20,000 breast cancer diagnoses every year.

Therefore, the escalating number of breast cancer cases and the surging use of the liquid biopsy technique for its diagnosis and staging are expected to steer the market growth in the upcoming years.